Resolvyx Pharmaceuticals

Theraputics for inflammatory diseases

Dedicated to the discovery and development
of therapeutics for inflammatory diseases

We are pioneering the development of Resolvin therapeutics, an entirely new class of medicines that treat disease by activating the body's own pathways to shut off inflammation.

Resolvins are highly effective small molecules with outstanding risk-benefit profiles, relevant to a wide range of acute and chronic diseases. They carry a number of benefits over classical therapeutics that inhibit inflammation, including:

  • Activate endogenous resolution pathways
  • Dampen entire networks of multiple pro-inflammatory mediators
  • Affect cells of both the innate and the adaptive arms of the immune system
  • Protect healthy tissue and promote tissue repair
  • Control inflammation without immunosuppression